Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer

This study has been terminated.
(Insufficient Accrual)
Information provided by (Responsible Party):
University of Southern California Identifier:
First received: September 8, 2005
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2006
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)